Drug Profile
Beclometasone dry-powder inhalation - GSK
Alternative Names: Beclometasone Accuhaler; Beclometasone Diskus; Beclomethasone Accuhaler; Beclomethasone Diskus; Beclomethasone dry-powder inhalation - GSK; Beclovent Rotacaps; Becodisks Diskhaler; Becotide Diskus; Becotide RotacapsLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Anti-inflammatories; Antiallergics; Antiasthmatics; Chlorinated steroids; Corticosteroids; Pregnadienetriols; Small molecules; Vascular disorder therapies
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Market Withdrawal Asthma
Most Recent Events
- 01 Feb 2012 Withdrawn for Asthma in United Kingdom (Becodisks Diskhaler, Inhalation)
- 31 Oct 2003 Withdrawn for Asthma in United Kingdom (Becotide Rotacaps, Inhalation)
- 23 Jan 2001 Glaxo Wellcome has merged with SmithKline Beecham to form GlaxoSmithKline